相似文献
1
Characteristics of Interim Publications of Randomized Clinical Trials and Comparison With Final Publications.
JAMA. 2018 Jan 23;319(4):404-406. doi: 10.1001/jama.2017.20653.
2
A comparison of matched interim analysis publications and final analysis publications in oncology clinical trials.
Ann Oncol. 2018 Dec 1;29(12):2384-2390. doi: 10.1093/annonc/mdy447.
3
Are our publications failing the inspection?: a review of the publications in rectal cancer surgery between 2002 and 2012.
Dis Colon Rectum. 2014 Aug;57(8):983-92. doi: 10.1097/DCR.0000000000000169.
4
Reporting on blinding in trial protocols and corresponding publications was often inadequate but rarely contradictory.
J Clin Epidemiol. 2009 Sep;62(9):967-73. doi: 10.1016/j.jclinepi.2009.04.003.
5
Problems with publishing results of interim analyses of randomized clinical trials.
HIV Clin Trials. 2000 Nov-Dec;1(3):30-6. doi: 10.1310/UD11-JYBQ-E1ME-9X79.
6
Reporting quality and information consistency of randomized, controlled trials presented as abstracts at the American Urological Association annual meetings.
J Urol. 2010 Jul;184(1):249-53. doi: 10.1016/j.juro.2010.03.045. Epub 2010 May 16.
7
An analysis of protocols and publications suggested that most discontinuations of clinical trials were not based on preplanned interim analyses or stopping rules.
J Clin Epidemiol. 2016 Jan;69:152-60. doi: 10.1016/j.jclinepi.2015.05.023. Epub 2015 Jun 4.
8
Publishing rehabilitation randomized controlled trials.
Stroke. 2006 Mar;37(3):766. doi: 10.1161/01.str.0000204240.67489.74.
9
A critical assessment of the quality of reporting of randomized, controlled trials in the urology literature.
J Urol. 2007 Mar;177(3):1090-4; discussion 1094-5. doi: 10.1016/j.juro.2006.10.027.
10
Trends in neonatology and pediatrics publications over the past 12 years.
Acta Paediatr. 2007 Jul;96(7):1080-2. doi: 10.1111/j.1651-2227.2007.00337.x. Epub 2007 May 24.
引用本文的文献
1
Preliminary analysis of self-reported quality health indicators of patients on opioid agonist therapy at specialty and primary care clinics in Ukraine: A randomized control trial.
PLOS Glob Public Health. 2022 Nov 2;2(11):e0000344. doi: 10.1371/journal.pgph.0000344. eCollection 2022.
2
Ethics in Psychiatric Research.
Indian J Psychiatry. 2022 Mar;64(Suppl 1):S68-S80. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_49_21. Epub 2022 Mar 22.
3
Interim versus final results of the trial-not the flip side of the same coin!
Indian J Thorac Cardiovasc Surg. 2018 Jul;34(3):333-334. doi: 10.1007/s12055-018-0682-7. Epub 2018 Jun 22.
4
Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis.
BMJ. 2019 Sep 18;366:l5221. doi: 10.1136/bmj.l5221.
5
Clinical trial publications.
Saudi J Anaesth. 2019 Apr;13(Suppl 1):S42-S43. doi: 10.4103/sja.SJA_575_18.
6
Assessment of Frequency and Reporting of Changes in Cancer Trial Design After Initiation of Patient Accrual.
JAMA Oncol. 2019 Jan 1;5(1):107-109. doi: 10.1001/jamaoncol.2018.5877.
7
Efficacy of a Carrageenan gel Against Transmission of Cervical HPV (CATCH): interim analysis of a randomized, double-blind, placebo-controlled, phase 2B trial.
Clin Microbiol Infect. 2019 Feb;25(2):210-216. doi: 10.1016/j.cmi.2018.04.012. Epub 2018 Apr 21.
本文引用的文献
1
Publishing interim results of randomised clinical trials in peer-reviewed journals.
Clin Trials. 2017 Feb;14(1):67-77. doi: 10.1177/1740774516664689. Epub 2016 Nov 26.
2
Quantifying over-estimation in early stopped clinical trials and the "freezing effect" on subsequent research.
Clin Trials. 2016 Dec;13(6):621-631. doi: 10.1177/1740774516649595. Epub 2016 Jun 7.
3
Interim results in clinical trials: do we need to keep all interim randomised clinical trial results confidential?
Lung Cancer. 2014 Aug;85(2):116-8. doi: 10.1016/j.lungcan.2014.05.012. Epub 2014 May 22.
4
High-dose imatinib induction followed by standard-dose maintenance in pre-treated chronic phase chronic myeloid leukemia patients--final analysis of a randomized, multicenter, phase III trial.
Haematologica. 2012 Oct;97(10):1562-9. doi: 10.3324/haematol.2011.060087. Epub 2012 Apr 17.
5
Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis.
JAMA. 2010 Mar 24;303(12):1180-7. doi: 10.1001/jama.2010.310.
6
High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" study.
Haematologica. 2010 Jun;95(6):908-13. doi: 10.3324/haematol.2009.013979. Epub 2010 Feb 9.
Zotero 插件